Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant
- 4 November 2014
- journal article
- case report
- Published by Wiley in Transplant Infectious Disease
- Vol. 16 (6) , 1003-1006
Abstract
Transmission of hepatitis C virus (HCV) to recipients of hematopoietic stem cell transplant (HSCT) occurs frequently from HCV viremic donors and causes complications. Here, we report the outcomes of 3 cases from our 265 allogeneic HSCTs, whose donors had HCV infections. Successful prevention of HCV transmission was noted in 1 recipient by pretreatment of the donor with peginterferon/ribavirin to undetectable levels of HCV viremia before stem cell harvest. This case stressed the important role of effective antiviral therapy and HCV RNA seronegativity before cell harvest for prevention of HCV transmission in HSCT.Keywords
This publication has 11 references indexed in Scilit:
- No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationTransplant Infectious Disease, 2012
- Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesHaematologica, 2009
- Suppressive Anti-HCV Therapy for Prevention of Donor to Recipient Transmission in Stem Cell TransplantationAmerican Journal of Gastroenterology, 2007
- Risk Factors for Perinatal Transmission of Hepatitis C Virus (HCV) and the Natural History of HCV Infection Acquired in InfancyThe Journal of Infectious Diseases, 2005
- Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipientsBone Marrow Transplantation, 2005
- Long-term outcome of hepatitis C infection after bone marrow transplantationBlood, 2004
- THE ROLE OF HEPATITIS C AND B VIRUS INFECTIONS AS RISK FACTORS FOR SEVERE LIVER COMPLICATIONS FOLLOWING ALLOGENEIC BMT: A PROSPECTIVE STUDY BY THE INFECTIOUS DISEASE WORKING PARTY OF THE EUROPEAN BLOOD AND MARROW TRANSPLANTATION GROUP1Transplantation, 1999
- Hepatitis C Virus Infection and Bone Marrow Transplantation: A Cohort Study With 10–Year Follow–UpHepatology, 1999
- PREVENTION OF TRANSMISSION OF HEPATITIS C VIRUS IN BONE MARROW TRANSPLANTATION BY TREATING THE DONOR WITH??-INTERFERON1Transplantation, 1996
- Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical courseBlood, 1994